Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation-Reference-Cited by-同舟云学术

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation

Published:2005-06-01 Issue:21 Volume:293 Page:2634
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Wazni Oussama M.,Marrouche Nassir F.,Martin David O.,Verma Atul,Bhargava Mandeep,Saliba Walid,Bash Dianna,Schweikert Robert,Brachmann Johannes,Gunther Jens,Gutleben Klaus,Pisano Ennio,Potenza Dominico,Fanelli Raffaele,Raviele Antonio,Themistoclakis Sakis,Rossillo Antonio,Bonso Aldo,Natale Andrea

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 919 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and economic impact of first-line or drug-naïve catheter ablation and delayed second-line catheter ablation for atrial fibrillation using a patient-level simulation model;Journal of Medical Economics;2024-09-10

2. Trends in safety of catheter-based electrophysiology procedures in the last 2 decades: A meta-analysis;Heart Rhythm;2024-09

3. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation;Heart Rhythm;2024-09

4. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

5. Procedural and Clinical Outcomes of High-Frequency-Low-Tidal-Volume Ventilation Plus Rapid-Atrial Pacing in Paroxysmal Atrial Fibrillation Ablation;2024-08-13